Arvinas Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include NextCure.

	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Founding Date	Founding Date 2018	Founding Date 2015
Type	Type Public	Type Public
Tags	Tags Healthcare biotech oncology platform therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy
Locations	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Beltsville, US HQ
Employees	Employees 188	Employees N/A
Valuation ($)	Valuation ($) 243.3 m	Valuation ($) 39.2 m
Financial
Net income	Net income ($274.4m) (FY, 2025)	Net income ($55.8m) (FY, 2025)

For sources of this data, please see the company profile

Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

Financial